The role of U2AF1 mutations in myelodysplastic syndrome: a noncanonical role for splicing factors in bone marrow failure
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210620
- Recipient
-
The Geneva Foundation UEI TR9RX33188T4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,054,546
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Funding
-
- $527,273.00 Federal
- $527,273.00 Non-federal
- Place of performance
- Tacoma, WA 98402, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Original award | $527,273 | $527,273 |
Quick answers
Who received award W81XWH2210620?
W81XWH2210620 was awarded to The Geneva Foundation by Defense Health Agency (Department of Defense) on July 15, 2022.
How much is award W81XWH2210620 worth?
$1,054,546 has been obligated on W81XWH2210620: $527,273 in federal funding and $527,273 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award